ArticleJournal of clinical pharmacology2026

Addressing a Common Misconception of Simple Additive and Cumulative Drug Inhibition: Multiple Weak Inhibitors of Common Metabolic Pathway Do Not Pose a Strong Interaction Risk!

Daniel Scotcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.